ETF Holdings Breakdown of BMRN

Stock NameBiomarin Pharmaceutical Inc
TickerBMRN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS09061G1013
LEINSLL8ITTRR0J5HEMR848

News associated with BMRN

Kentucky Retirement Systems Buys New Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Kentucky Retirement Systems bought a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, HoldingsChannel.com reports. The institutional investor bought 12,890 shares of the biotechnology company’s stock, valued at approximately $911,000. Other hedge funds have also recently added to or reduced their stakes in the company. Farther Finance […] - 2025-06-25 08:40:49
Exchange Traded Concepts LLC Acquires 979 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Exchange Traded Concepts LLC boosted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 5.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,796 shares of the biotechnology company’s stock after acquiring an additional 979 shares during the quarter. Exchange Traded […] - 2025-06-19 07:58:54
Mn Services Vermogensbeheer B.V. Boosts Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Mn Services Vermogensbeheer B.V. increased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.0% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 35,500 shares of the biotechnology company’s stock after buying an additional 3,800 shares during the period. Mn Services Vermogensbeheer […] - 2025-06-18 08:44:54
NorthCrest Asset Manangement LLC Acquires Shares of 4,885 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
NorthCrest Asset Manangement LLC acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 4,885 shares of the biotechnology company’s stock, valued at approximately $345,000. Other hedge funds and […] - 2025-06-16 08:36:54
UMB Bank n.a. Increases Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
UMB Bank n.a. grew its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 120.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,247 shares of the biotechnology company’s stock after acquiring an additional 1,228 shares during the period. UMB Bank […] - 2025-06-12 08:32:57
Gateway Investment Advisers LLC Cuts Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Gateway Investment Advisers LLC lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 22.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,512 shares of the biotechnology company’s stock after selling 1,003 shares during the period. Gateway Investment Advisers LLC’s […] - 2025-06-10 08:26:59
Tidal Investments LLC Sells 17,428 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Tidal Investments LLC lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 57.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,039 shares of the biotechnology company’s stock after selling 17,428 shares during the quarter. Tidal Investments LLC’s holdings in BioMarin […] - 2025-05-27 08:21:04
Quantinno Capital Management LP Purchases Shares of 5,848 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Quantinno Capital Management LP bought a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 5,848 shares of the biotechnology company’s stock, valued at approximately $384,000. A number […] - 2025-05-26 07:58:58
BioMarin To Acquire Inozyme Pharma For About $270 Mln In Cash
(RTTNews) - BioMarin Pharmaceutical Inc. (BMRN) and Inozyme Pharma, Inc. (INZY) Friday said that BioMarin has agreed to acquire Inozyme for about $270 million or $4 per share, in cash. - 2025-05-16 11:51:10
BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Lowered to $104.00 at The Goldman Sachs Group
BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its price target cut by The Goldman Sachs Group from $124.00 to $104.00 in a research report sent to investors on Monday,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. Other research analysts have also issued reports about the company. Oppenheimer raised BioMarin Pharmaceutical […] - 2025-05-06 05:56:44
NewEdge Advisors LLC Purchases 3,121 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
NewEdge Advisors LLC increased its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 1,200.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,381 shares of the biotechnology company’s stock after buying an additional 3,121 shares during the […] - 2025-05-02 08:18:50
BioMarin Pharmaceutical (NASDAQ:BMRN) Upgraded at StockNews.com
StockNews.com upgraded shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Friday. BMRN has been the topic of several other reports. Scotiabank lifted their price objective on shares of BioMarin Pharmaceutical from $78.00 to $80.00 and gave the stock a […] - 2025-04-28 05:56:51
After Hours Most Active for Apr 22, 2025 : TSLL, TSLA, NVDA, VZ, BMRN, CNH, KVUE, CM, CSCO, CLF, BAC, AAPL
The NASDAQ 100 After Hours Indicator is down -.37 to 18,276.04. The total After hours volume is currently 133,305,492 shares traded.The following are the most active stocks for the after hours session: Direxion Daily TSLA Bull 2X Shares (TSLL) is -0.1 at $7.29, with 10,940,890 s - 2025-04-22 20:24:52
Federated Hermes Inc. Sells 854 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Federated Hermes Inc. lessened its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 4.3% in the 4th quarter, HoldingsChannel.com reports. The fund owned 18,999 shares of the biotechnology company’s stock after selling 854 shares during the period. Federated Hermes Inc.’s holdings in BioMarin Pharmaceutical were worth $1,249,000 at the end of […] - 2025-04-15 08:34:53
CIBC Private Wealth Group LLC Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
CIBC Private Wealth Group LLC boosted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 64.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 596 shares of the biotechnology company’s stock after acquiring an additional 233 shares during […] - 2025-04-10 08:53:11
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $94.00 Consensus Target Price from Brokerages
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-four ratings firms that are presently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a hold rating and seventeen have issued a buy rating on the company. The average 12-month target price […] - 2025-04-02 05:35:01
Korea Investment CORP Purchases 131,600 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Korea Investment CORP grew its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 362.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 167,903 shares of the biotechnology company’s stock after purchasing an additional 131,600 shares during the quarter. Korea […] - 2025-03-31 08:45:10
Traders Purchase High Volume of Call Options on BioMarin Pharmaceutical (NASDAQ:BMRN)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) was the target of some unusual options trading on Thursday. Traders bought 5,111 call options on the company. This represents an increase of 273% compared to the typical volume of 1,372 call options. Analyst Ratings Changes BMRN has been the subject of several recent analyst reports. Wedbush […] - 2025-03-28 07:07:10
Natixis Advisors LLC Purchases Shares of 19,738 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Natixis Advisors LLC acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 19,738 shares of the biotechnology company’s stock, valued at approximately $1,297,000. A number of other institutional investors and hedge […] - 2025-03-26 07:50:56
EverSource Wealth Advisors LLC Sells 6,469 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
EverSource Wealth Advisors LLC lowered its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 91.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 634 shares of the biotechnology company’s stock after selling 6,469 shares during the quarter. EverSource Wealth Advisors […] - 2025-03-21 08:25:03
BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Rating Upgraded by StockNews.com
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Tuesday. BMRN has been the subject of several other research reports. Oppenheimer upgraded shares of BioMarin Pharmaceutical from a “market perform” rating to an “outperform” rating […] - 2025-03-18 06:12:54
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Acquired by M&T Bank Corp
M&T Bank Corp lifted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 9.5% during the fourth quarter, HoldingsChannel.com reports. The firm owned 7,085 shares of the biotechnology company’s stock after purchasing an additional 616 shares during the period. M&T Bank Corp’s holdings in BioMarin Pharmaceutical were worth $466,000 at the […] - 2025-03-14 08:08:58
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-four brokerages that are presently covering the stock, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation and seventeen have issued a buy recommendation on the company. The average 12-month price […] - 2025-03-05 07:12:53
Y Intercept Hong Kong Ltd Has $310,000 Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Y Intercept Hong Kong Ltd lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 83.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,711 shares of the biotechnology company’s stock after selling 23,519 shares during the quarter. […] - 2025-03-04 09:05:03
Sanctuary Advisors LLC Trims Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Sanctuary Advisors LLC lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 76.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,045 shares of the biotechnology company’s stock after selling 16,288 shares during the quarter. Sanctuary […] - 2025-03-04 08:22:48
New York State Common Retirement Fund Sells 4,600 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
New York State Common Retirement Fund reduced its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 4.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 93,645 shares of the biotechnology company’s stock after selling 4,600 shares during […] - 2025-02-28 09:04:56
Principal Securities Inc. Acquires 339 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Principal Securities Inc. boosted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 24.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,749 shares of the biotechnology company’s stock after buying an additional 339 shares […] - 2025-02-26 10:10:52
Asset Management One Co. Ltd. Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Asset Management One Co. Ltd. raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 76,785 shares of the biotechnology company’s stock after acquiring an additional 283 shares during the period. Asset Management One Co. Ltd.’s holdings in BioMarin Pharmaceutical were worth […] - 2025-02-19 10:44:54
Rhumbline Advisers Has $36.56 Million Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Rhumbline Advisers boosted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 2.0% in the fourth quarter, Holdings Channel reports. The firm owned 556,255 shares of the biotechnology company’s stock after purchasing an additional 11,025 shares during the quarter. Rhumbline Advisers’ holdings in BioMarin Pharmaceutical were worth $36,563,000 as of its most recent […] - 2025-02-19 09:03:32
Entropy Technologies LP Invests $500,000 in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Entropy Technologies LP acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,604 shares of the biotechnology company’s stock, valued at approximately $500,000. Other large […] - 2025-02-13 10:12:51

BMRN institutional holdings

The following institutional investment holdings of BMRN have been identified

Date ETF ISIN/Name Num Shares Book value
2025-06-23 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 285,062USD 15,416,153
2025-06-23 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 285,062USD 15,416,153 -1.7%
2025-06-23 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 285,062USD 15,416,153
2025-06-23 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 285,062USD 15,416,153
2025-06-23 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 31,893USD 1,724,773 -1.7%
2025-06-23 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 57,050USD 3,085,264 -1.7%
2025-06-23 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 57,334USD 3,100,623
2025-06-23 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 57,334USD 3,100,623
2025-06-23 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 57,334USD 3,100,623
2025-04-14 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc)) 11,427 200.0%USD 681,849 195.2%
2025-04-14 IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist)) 11,427 200.0%USD 681,849 195.2%
2025-06-23 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 19,031 -0.2%USD 1,029,196 -1.9%
2025-06-23 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 3,689USD 199,501
2025-06-23 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 3,689USD 199,501
2025-06-23 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 15,311USD 828,019
2025-06-23 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 15,311USD 828,019
2025-06-23 IE00B8FHGS14 (iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc)) 116,794USD 6,316,220
2025-06-23 IE00BGPP8L80 (iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc)) 116,794USD 6,316,220
2025-06-23 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 11,434USD 536,274 -1.8%
2025-06-23 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 6,630USD 358,550
2025-06-23 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 4,194USD 226,812
2025-06-23 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 4,112USD 222,377
2025-06-23 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 4,112USD 222,377
2025-06-23 IE00B27YCN58 (iShares MSCI World Islamic UCITS ETF USD (Dist) USD) 8,338USD 450,919 -1.7%
2025-06-23 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 95,044USD 5,139,980
2025-06-23 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 95,044USD 5,139,980
2025-06-23 IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)) 1,348USD 72,900
2025-06-23 IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc)) 1,348USD 72,900
2025-06-23 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 993USD 39,813
2025-06-23 IE00BP3QZD73 (iShares MSCI World Mid-Cap Equal Weight UCITS ETF USD (Acc)) 6,481USD 350,492
2025-06-23 IE00BD1F4K20 (iShares MSCI USA Mid-Cap Equal Weight UCITS ETF USD (Acc)) 16,816USD 909,409
2025-06-23 IE00B296QM64 (iShares MSCI USA Islamic UCITS) 3,971USD 214,752
2025-06-23 IE00BKM4H197 (iShares MSCI EM Consumer Growth UCITS ETF) 1,034USD 55,919 -1.7%
2025-06-23 IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF) 1,276USD 69,006
2025-06-23 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 57,050USD 3,085,264 -1.7%
2025-06-23 IE0009VWHAE6 (iShares US Equity Enhanced Active UCITS ETF USD (Acc)) 9,999USD 540,746
2024-11-08 IE000X08RX14 (iShares MSCI World ESG Enhanced UCITS ETF NZD Hedged (Acc)) 3,362USD 225,489 0.2%
2025-06-23 IE000KJPDY61 (iShares World Equity High Income UCITS ETF USD Inc) 1,357USD 73,387
2025-05-12 IE000WHL2ZK1 (iShares U.S. Equity High Income UCITS ETF USD Inc) 696USD 42,714 4.1%
2025-06-23 IE000D8XC064 (iShares World Equity Enhanced Active UCITS ETF USD (Acc)) 3,792USD 205,071
2025-05-29 IE0002PA3YE5 (iShares MSCI USA Momentum Factor ESG UCITS ETF USD (Acc)) 39USD 2,283 0.7%
2025-05-20 IE0007O06KL9 (iShares Russell 2000 Swap UCITS ETF) 1,137 200.0%USD 68,140 199.1%
2025-06-23 IE0002W8NB38 (iShares MSCI USA Swap UCITS ETF USD (Acc)) 3,301USD 178,518
Total =2,057,574 USD 111,360,964
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.